What is Aviwell?
Founded in France, Aviwell is at the forefront of animal nutrition innovation, specializing in next-generation, microbiome-based solutions designed to enhance animal health, boost performance, and improve robustness. The company utilizes its proprietary Aneto AI-driven discovery platform to engineer native bacterial ecologies with precise modes of action. These solutions aim to support productivity while concurrently reducing the reliance on antibiotics, addressing critical sustainability challenges within the poultry and aquaculture industries. Aviwell's focus on deep-tech and AI positions it as a key player in advancing sustainable practices in global agri-food systems.
How much funding has Aviwell raised?
Aviwell has raised a total of $22.9M across 2 funding rounds:
Angel/Seed
$10M
Series A
$12.9M
Angel/Seed (2023): $10M with participation from MFS and Elaia Partners
Series A (2026): $12.9M led by Hatch Blue, Blast Club, and SWEN Capital Partners
Key Investors in Aviwell
MFS
MFS, established in 1924 and headquartered in Boston, Massachusetts, is a global asset manager with extensive experience in investment management.
Elaia Partners
Elaia Partners is a full-stack investor specializing in tech disruptors, supporting ambitious entrepreneurs from inception to leadership with a focus on performance and values.
Hatch Blue
Hatch Blue is a global firm dedicated to sustainable growth and innovation in aquaculture, focusing on regenerative farming and technology advancements.
What's next for Aviwell?
With the recent influx of major strategic investment, Aviwell is poised for significant expansion and further development of its Aneto AI platform. The company's focus on sustainable animal nutrition, particularly for poultry and aquaculture, aligns with growing global demand for antibiotic-free production and environmentally conscious agri-food practices. This enterprise-level backing will likely fuel advancements in their product pipeline, market penetration, and research into novel microbiome-based solutions. Aviwell's trajectory suggests a strong emphasis on scaling its operations and solidifying its position as a leader in deep-tech animal health.
See full Aviwell company page
